Medical College of Nanjing University, Research Institute of General Surgery, Nanjing General Hospital of Nanjing Military Command, Nanjing, China.
Surgery. 2010 Apr;147(4):542-52. doi: 10.1016/j.surg.2009.10.036. Epub 2009 Dec 11.
Our objective was to compare the effect of a restricted intravenous fluid regimen adjusted by serum lactate level with a standard restricted regimen on complications after major elective surgery for gastrointestinal malignancy.
This is a randomized, observer-blinded, single-center trial conducted across a time span of 13 months. A total of 299 patients were allocated to either a restricted intravenous fluid regimen with supplementary intravenous fluids given based on serum lactate level (group A) or a standard restricted regimen (group R). In group A, the serum lactate level was monitored closely postoperatively to maintain a normal pre-operative serum lactate level. Group R involved patients treated with a restricted fluid regimen in whom additional fluid and electrolytes were administered when deemed necessary based on the usual clinical criteria. The primary outcome measure was complications; the secondary measures were death and adverse effects.
Additional fluid supplementation was needed in some patients in both groups (group A [28%] vs group R [26%]). In group A, the time for additional fluid infusion occurred earlier in the postoperative period than group R. Patients in group A received their first supplementary fluid treatment within the first 12 h more commonly than those in group R (74% vs 37%, respectively; P < .004). The regimen adjusted by serum lactate decreased systemic postoperative complications in group A versus group R (10% vs 22%, respectively; P = .023) but not overall total complications (23% vs 33%, respectively; P = .090). In contrast, in patients who required additional fluid infusion, the difference in complications between the 2 groups was greater (overall complication, 45% vs 85%, respectively; P = .023; major complication, 16% vs 44%, respectively; P = .018; systemic complications, 19% vs 63%, respectively; P = .001). One patient died in group A and 4 died in group R (1% vs 4%, respectively; P = .206).
A fluid-restricted regimen after elective gastrointestinal operations for malignancy may lead to fluid insufficiency and low tissue perfusion in up to 28% of patients. Close monitoring of serum lactate levels with adjustment of intravenous fluid administration intraoperatively and in the early postoperative period may improve the early detection and correction of inadequate tissue perfusion, thereby decreasing the rate of complications.
我们的目的是比较通过血清乳酸水平调整的限制静脉输液方案与标准限制方案对胃肠道恶性肿瘤择期大手术后并发症的影响。
这是一项在 13 个月时间跨度内进行的随机、观察者设盲、单中心试验。共有 299 名患者被分配到接受基于血清乳酸水平的限制静脉输液方案(A 组)或标准限制方案(R 组)。在 A 组中,术后密切监测血清乳酸水平,以维持正常的术前血清乳酸水平。R 组中,患者接受限制液体治疗,根据常规临床标准,当认为有必要时给予额外的液体和电解质。主要观察指标是并发症;次要观察指标是死亡和不良反应。
两组中均有部分患者需要补充液体(A 组[28%] vs R 组[26%])。在 A 组中,术后需要额外补液的时间早于 R 组。A 组患者在术后 12 小时内接受首次补充液体治疗的比例高于 R 组(分别为 74%和 37%;P<0.004)。与 R 组相比,A 组通过血清乳酸调整的方案降低了术后全身并发症的发生率(分别为 10%和 22%;P=0.023),但并未降低总并发症的发生率(分别为 23%和 33%;P=0.090)。相反,在需要额外补液的患者中,两组之间的并发症差异更大(总并发症分别为 45%和 85%;P=0.023;主要并发症分别为 16%和 44%;P=0.018;全身并发症分别为 19%和 63%;P=0.001)。A 组中有 1 例患者死亡,R 组中有 4 例患者死亡(分别为 1%和 4%;P=0.206)。
在胃肠道恶性肿瘤择期手术中采用限制液体治疗方案可能导致多达 28%的患者出现液体不足和组织灌注不足。通过术中及术后早期监测血清乳酸水平并调整静脉输液,可能有助于早期发现和纠正组织灌注不足,从而降低并发症发生率。